Sivik Global Healthcare LLC Raises Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Sivik Global Healthcare LLC lifted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 35.6% in the 4th quarter, Holdings Channel reports. The fund owned 135,588 shares of the exchange traded fund’s stock after buying an additional 35,588 shares during the quarter. SPDR S&P Biotech ETF accounts for approximately 5.1% of Sivik Global Healthcare LLC’s holdings, making the stock its largest position. Sivik Global Healthcare LLC’s holdings in SPDR S&P Biotech ETF were worth $12,107,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in XBI. EPG Wealth Management LLC boosted its stake in SPDR S&P Biotech ETF by 152.7% in the 3rd quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock worth $34,000 after purchasing an additional 278 shares during the period. Tennessee Valley Asset Management Partners bought a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $44,000. Wetzel Investment Advisors Inc. purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $45,000. Sheets Smith Wealth Management bought a new position in shares of SPDR S&P Biotech ETF in the third quarter worth $55,000. Finally, Life Planning Partners Inc bought a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at $64,000.

SPDR S&P Biotech ETF Price Performance

NYSEARCA XBI traded down $0.90 during trading on Tuesday, reaching $84.62. The company’s stock had a trading volume of 7,413,647 shares, compared to its average volume of 11,658,005. The firm has a fifty day moving average of $92.54 and a 200 day moving average of $84.94. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52. The stock has a market capitalization of $6.57 billion, a PE ratio of 11.47 and a beta of 1.08.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.